Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,537
Total Claims
$700K
Drug Cost
636
Beneficiaries
$1,101
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+29%
Opioid rate vs peers
3.3% vs 2.6% avg
+3%
Cost per patient vs peers
$1,101 vs $1,068 avg
+23%
Brand preference vs peers
11.0% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.3%
Opioid Rate
317
Opioid Claims
$4,904
Opioid Cost
9.8%
Long-Acting Rate
Brand vs Generic
Brand: 1,047 claims · $555K
Generic: 8,436 claims · $143K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 100 | $101K |
| Empagliflozin | 99 | $81K |
| Fluticasone/Umeclidin/Vilanter | 52 | $44K |
| Tirzepatide | 30 | $44K |
| Sitagliptin Phosphate | 38 | $26K |
| Mirabegron | 33 | $23K |
| Dulaglutide | 21 | $21K |
| Budesonide/Glycopyr/Formoterol | 21 | $17K |
| Semaglutide | 12 | $16K |
| Rsvpref3 Antigen/As01e/Pf | 46 | $15K |
| Linagliptin | 19 | $14K |
| Budesonide/Formoterol Fumarate | 17 | $9,783 |
| Atorvastatin Calcium | 707 | $8,697 |
| Ubrogepant | 12 | $7,846 |
| Vibegron | 14 | $7,167 |
Prescribing Profile
Patient Profile
73
Avg Age
49%
Female
1.08
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About